how the European nugget InstaDeep seduces companies
By Ingrid Vergara Posted 1 minute ago , Update 1 minute ago Karim Beguir, CEO…
1 minute ago
Update 1 minute ago
Karim Beguir, CEO and co-founder of InstaDeep, in Abidjan, in 2022. ISSOUF SANOGO/AFP
The start-up, acquired by BioNTech in January, is one of the most promising AI companies on the Old Continent.
Their first collaboration gave birth to the first early warning system making it possible to predict very quickly, from their genetic code, the appearance and evolution of the most dangerous variants of Covid-19. The capabilities of young artificial intelligence (AI) company InstaDeep impressed so much BioNTech that the German laboratory bought it at the start of the year for 636 million euros. Unheard of so far in Europe in this AI sector. Becoming a subsidiary of BioNTech, based in London, InstaDeep will allow the laboratory to integrate the constantly evolving capacities of artificial intelligence into its biotechnologies. “Goal is to create a leader in the development of next-generation immunotherapy, to help fight cancer and other diseases», emphasizes Karim Beguir, CEO and co-founder of InstaDeep.
But beyond this sector, the company aims to become a technological leader in AI for companies in Europe. InstaDeep…